Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect study of single-dose TAK-385 in healthy premenopausal women
jRCT2080223218Phase 1
- Sponsor
- Takeda
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tissue-plasminogen activator (3 arms), sponsored by Takeda.
02
Drugs
tissue-plasminogen activator
Beyond the preview
Go deeper on jRCT2080223218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223218.